logo
Share SHARE
FONT-SIZE Plus   Neg

Nanosphere Obtains CE Mark For Gram-Negative Blood Culture Test

Healthcare company Nanosphere, Inc. (NSPH: Quote) Wednesday said it has obtained the CE IVD Mark, under the European Directive on In Vitro Diagnostic Medical Devices, for its Gram-Negative Blood Culture test or BC-GN on the automated sample-to-result Verigene System.

The CE IVD Mark is a requirement for in vitro diagnostic medical devices marketed in Europe.

The company said the test expands its infectious disease test capabilities to include rapid detection of bacteria that can cause deadly bloodstream infections. It further added that, with a single automated test, the Verigene BC-GN test provides rapid genus and species level detection for a broad panel of clinically significant gram-negative bacteria and also detects critical genetic markers of antimicrobial resistance, including KPC, NDM, CTX-M, OXA, VIM, and IMP.

Commenting on the development, Michael McGarrity, Nanosphere's Chief Executive Officer said, "The Gram-Negative Blood Culture test provides clinicians a revolutionary diagnostic tool for the simultaneous detection of disease-causing gram-negative bacteria and accompanying antibiotic resistance markers in a clinically actionable timeframe."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Fortune has once again named Google Inc. (GOOG, GOOGL) as the best company to work for, with Twitter Inc. (TWTR) also joining the annual list for the first time. This is for the sixth time and for the fourth consecutive time that Google has ranked No.1 in the Fortune's annual list of "100 Best Companies... Dunkin' Donuts has agreed to remove a whitening agent called titanium dioxide, commonly a source of nanomaterials, from all powdered sugar used in its donuts. The move follows pressure from advocacy group As You Sow, which put a shareholder proposal asking Dunkin' to reduce the risks of using nanomaterials in its food products. Warren Buffett's Berkshire Hathaway is reportedly planning its first ever European bond sale of 3 billion euros to take advantage of low interest rates in the region, traversing a path taken by a range of home companies in search of cheap funding options. The move comes as the European Central Bank's bond-buying stimulus program of 60 billion euros a month is imminent.
comments powered by Disqus
Follow RTT